Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30014486HIVENSG00000117676.14protein_codingRPS6KA1NoNo6195Q15418
TVIS30014487HIVENSG00000117676.14protein_codingRPS6KA1NoNo6195Q15418
TVIS20047243HPVENSG00000117676.14protein_codingRPS6KA1NoNo6195Q15418
TVIS20048525HPVENSG00000117676.14protein_codingRPS6KA1NoNo6195Q15418
TVIS44043916HTLV-1ENSG00000117676.14protein_codingRPS6KA1NoNo6195Q15418
TVIS44043915HTLV-1ENSG00000117676.14protein_codingRPS6KA1NoNo6195Q15418
TVIS44043914HTLV-1ENSG00000117676.14protein_codingRPS6KA1NoNo6195Q15418
TVIS44043913HTLV-1ENSG00000117676.14protein_codingRPS6KA1NoNo6195Q15418
TVIS44043912HTLV-1ENSG00000117676.14protein_codingRPS6KA1NoNo6195Q15418
TVIS44043911HTLV-1ENSG00000117676.14protein_codingRPS6KA1NoNo6195Q15418
TCGA Plot Options
Drug Information
GeneRPS6KA1
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0004274
UniProt IDQ15418
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830